
TSE:CLS
Keeps going up. Business has totally morphed into value-added parts in the semiconductor space. Riding the wave of massive growth of all chipmakers. Valuation seems reasonable. Remember that semis are cyclical; ASML, for example, went down 20% yesterday. Hot stocks always have potential to re-rate.
Quite well run, but not ready to be there. His preference is TSM, but its valuation is not attractive either.
Trending higher above the 200-day MA, which itself is moving higher. Watch it in terms of how far the valuation goes. Right now, 15x forward earnings with about a 13% growth rate for 2025, 29% for 2026. Valuation is actually not as expensive as a lot of other tech names, especially in the US. Valuation and technicals look decent.
12-month price target of $79, still a bit of room. On the chart, you can see the highs that go back to the early summer. Buy 1/3 here around $68, another at just under $64 where there seems to be some support, and the final 1/3 at just over $60. Put in a stop around $54-55.
Concentration risk, but its manufacturing and platform solutions are state of the art. Client base includes hyperscalers and service providers. Extremely well run.
Pulled back in July, rallied to a lower high, now has pulled back to just above the rising 200-day MA. Price pattern is a lot like big tech. Hold, but don't add. If you own it, use the 200-day as a line in the sand. Watch those lows from July. Be cautious. If it breaks $60, need to have a hard discussion.
With this type of stock, he asks himself whether it's just not better to own NVDA? CLS is benefiting today from data centre buildout and relationship with GOOG (an open secret). Those dynamics don't make them the best position in the value chain relative to NVDA and other players.
It's the end of the bullwhip effect. NVDA is the real, bleeding-edge innovator in the ecosystem. Sell CLS, and roll the gains into NVDA.
The chart is going straight up. They're moving from contract producers of electronics for others to consulting and apps. Earnings forecast is rising. The question is how long this will go. The last time the chart did this was in 2000. If it returns to its 2000 level, shares could double. He wouldn't sell now.
Probably overbought here, up 240% in last 12 months. 21-22x forward earnings, 15-16% EPS growth rate. Not really expensive. Likes it.